Apr. 9 at 11:40 AM
$ENTX New Cap Notes Report: Bones of a Bet: Why the Smart Money That Backed ChemoCentryx, Blueprint and Protagonist Just Put Its Chips on Entera Bio
https://capnotes.beehiiv.com/p/bones-of-a-bet-why-the-smart-money-that-backed-chemocentryx-blueprint-and-protagonist-just-put-its-c
The fund that backed ChemoCentryx (
$3.7B exit), Blueprint Medicines (
$9.1B exit) and Protagonist Therapeutics (
$5.9B+ valuation) just invested in Entera Bio – a
$54 million company developing the world’s first oral bone-building pill, with Phase 3 on the launchpad and an FDA response due in weeks.
$CCXI $BPMC $PTGX $VKTX